Cellular and Molecular Biology
Open Access

In all eukaryotes, prior mitochondria are utilized as formats to fabricate more mitochondrial mass, in front of cell division or in light of expanded metabolic interest. All proteins imported across the outer mitochondrial membrane enter through a protein translocase known as the TOM complex during mitochondrial biogenesis, which necessitates the import of up to 1,000 distinct proteins into the organelle. This complex is a momentous nano-machine made out of a center framed by the β-barrel channel Tom40 and extra subunits, every one of which has a solitary α-helical transmembrane fragment [1].

Tail-anchored proteins make up Tom5, Tom6, Tom7, and Tom22, the subunits that surround the Tom40 barrel. It is certain that Tom7 and Tom22 existed in the earliest stages of mitochondrial evolution in the ancestral TOM complex. The sorting and assembly machinery is responsible for the process by which the other two tail-anchored proteins, Tom5 and Tom6, are attached to newly integrated Tom40 molecules at an early stage of the TOM complex's assembly into the outer membrane. Harbauer's most recent research now demonstrates that the cell cycle coordinates the regulation of the TOM complex's activity and, consequently, mitochondrial protein import [2].

The cell biology research that led to the Nobel Prize-winning understanding of the cell cycle utilised the yeast Saccharomyces cerevisiae as a crucial experimental model. Treatment with the mating pheromone -factor can stop yeast strains of mating type a in the G1 phase of the cell cycle. A culture of yeast that has been synchronized in this manner will advance together through the periods of the cell cycle and can be tested at standard spans to decide cell-cycle-subordinate aggregates. A far reaching examination of the dynamic transcriptome in the phone cycle utilizing this technique uncovered that, of the different parts of the TOM complicated, just the mRNA for Tom6 increments during M stage. A cell-cycle-dependent increase in TOM6 gene transcription or a post-transcriptional mechanism that reduces TOM6 mRNA turnover in a cell-cycle-dependent manner could be the cause of this change in transcript levels [3]. Harbauer observed that there was an extremely clear expansion in the consistent state level of Tom6 protein in the M period of the cell cycle.

How is this expansion in Tom6 protein level authorized? The simplest explanation is that more Tom6 protein is translated when there is more TOM6 mRNA. Although this is true, the steady-state level of membrane proteins also depends on how well the very hydrophobic protein can be targeted to the right membrane and assembled into the membrane. The mRNA-localizing protein Puf3 and the localized translation of membrane proteins at the mitochondrial surface are two of the mechanisms that play a role in regulating the effectiveness of targeting and assembly of mitochondrial membranes [4]. In the new review, Harbauer currently show that, on account of Tom6, a key administrative component is applied through the cyclin-subordinate kinase CDK1, an expert controller of the cell cycle in all eukaryotes, with CDK1 intervening cell-cycle-subordinate phosphorylation of Tom6.

The serine residue at position 16 in Tom6 was among the TOM complex's phosphorylation sites that Schmidt had previously discovered and catalogued. Casein kinase 2 and the cAMP-dependent protein kinase mediate some of these phosphorylation events in response to various environmental stimuli. Harbauer created biochemical assays to directly demonstrate that CDK1 is the mediator of Tom6 phosphorylation and that phosphorylated Tom6 is more effectively assembled into the mitochondrial outer membrane. In addition, the increased levels of Tom6 help to increase Tom40's assembly into the outer membrane: To "dial up" or "dial down" the amount of TOM complex carried by mitochondria, the steady-state level of Tom6 acts as a rheostat [5, 6]. In turn, this rheostat is controlled by the cyclin Clb3, which is the specific stimulus that causes CDK1 to be activated and causes Tom6 to phosphorylate Ser16. Since Clb3 is only active during M phase, its expression is tightly controlled.

This paper's compelling findings are based on multiple research avenues. The authors have utilized phosphomimetic forms of Tom6 in both biochemical assays and in vivo phenotypic analysis, in addition to the conventional method of using cell synchronization to produce extracts to monitor protein levels and to purify active mitochondria for in vitro analysis. Utilizing a glutamate substitution in place of a serine to mimic the phosphorylated form of the protein of interest is extremely useful for in vivo studies. In a similar vein, a protein that does not contain phosphorylation can be represented by substituting alanine or valine for serine [7]. The protein was imported with increased efficiency, accumulated to higher steady-state levels, and promoted the increased level and activity of the TOM complex, mimicking the effect of phosphorylated Tom6, according to the new study's expression of Tom6 (S16E). This protein was imported less effectively, was present at lower steady-state levels, and failed to promote the activity of the TOM complex, mimicking the effect of constitutively de-phosphorylated Tom6 in a yeast strain that expressed Tom6(S16A), a form of Tom6 that is not phosphorylatable [8]. Since the TOM complex is the door for protein import into mitochondria, more elevated levels of the TOM complex can clear a path for the import of more protein, to construct more mitochondria. The study by Harbauer adds to our comprehension of how mitochondrial biogenesis is controlled by the cell cycle.

By explicitly seeing proteins expanded 'per unit mitochondria', a noteworthy increment was found in two administrative GTPases, Fzo1 and Mgm1, which assume a part in mitochondrial layer combination occasions that can increment cell ATP creation significantly further. An in-depth, systems-level comprehension of "why" and "how" mitochondrial biogenesis kicks into high gear is now in place. In cell biology, this is important. In the majority of organisms, the primary function of mitochondria is to maximize the energy currency returns from investments made in securing carbon from the environment.

Through the activity of mitochondria, carbon got from sugars and fats can be utilized to deliver a maximal measure of ATP, in any case, at a frameworks level, there is an extraordinary oddity in the utilization of this organelle. It takes a lot of ATP to translate the thousands of proteins needed to build mitochondrial mass, transport, fold, and assemble them into a mitochondrion [9, 10]. It is likewise exorbitant, in term of ATP utilization, to supplant the electron-transport buildings wore out by oxidative harm throughout ATP creation, and to reproduce the mitochondrial DNA and translate the mitochondrial RNAs that encode a few of the electron-transport proteins. Therefore, it is not surprising that the amount of mitochondrial mass that accumulates during each cycle of the cell cycle is carefully controlled to ensure that the cell receives the maximum benefit from its energy investments.

1. Yu J, Sun L, Hao T, Zhang B, Chen X, et al. (2019) Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer. Ann Transl Med 7: 729.

Google Scholar, Crossref, Indexed at

2. Díaz de la Guardia-Bolívar E, Barrios-Rodríguez R, Zwir I, Jiménez-Moleón J, Del Val C (2022) Identification of novel prostate cancer genes in patients stratified by Gleason classification: role of antitumoral genes. Int J Cancer.

Indexed at, Google Scholar, Crossref

3. Gennarino V, Alcott C, Chen C, Chaudhury A, Gillentine M, et al. (2015) NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation. Elife 4: e10782.

Google Scholar, Crossref, Indexed at

4. Brumbaugh J, Di Stefano B, Wang X, Borkent M, Forouzmand E, et al. (2018) Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling. Cell 172: 106-120.

Google Scholar, Crossref, Indexed at

5. Szczepanek J, Styczyński J, Tretyn A, Pogorzała M, Wysocki M (2012) Identification of the genes expression profile associated with the ex vivo resistance to etoposide in childhood acute leukemias. Postepy Hig Med Doswy 66: 401-408.

Google Scholar, Crossref, Indexed at

6. Zhu Y, Zhang R, Zhang Y, Cheng X, Li L, et al. (2021) NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer. Frontiers Onc 11: 670353.

Google Scholar, Crossref, Indexed at

7. Lang X, Zhao W, Huang D, Liu W, Shen H, et al. (2019) The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia. J Cell Mol Med 23: 3202-3213.

Google Scholar, Crossref, Indexed at

8. Zheng Y, Chen M, Lei W, Zhu S, You X, et al. (2020) NUDT21 knockdown inhibits proliferation and promotes apoptosis of pancreatic ductal adenocarcinoma through EIF2 signaling. Exp Cell Res 395: 112182.

Google Scholar, Crossref, Indexed at

9. Wang X, Zhang Y, Xiao J, Zhang K, Li Q, et al. (2018) 18 beta-glycyrrhetinic acid ameliorates the cognitive functions and decreases the recurrence rate of pituitary adenomas patients. Excli J 17: 753-761.

Google Scholar, Crossref, Indexed at

10. Lou J, Lan Y, Gao J, Ma B, Yang T, et al. (2017) Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway. Front Mol Neurosci 10: 420.

Google Scholar, Indexed at